Cytosorbents
CTSO
#10785
Rank
A$26.88 M
Marketcap
A$8.53
Share price
22.92%
Change (1 day)
670.08%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2026 (TTM): -A$27.41 Million

According to Cytosorbents's latest financial reports the company's current earnings are A$37.21 Million. In 2025 the company made an earning of -A$12.44 Million, an increase over its 2024 earnings that were of -A$32.87 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$27.41 Million120.38%
2025 -A$12.44 Million-62.16%
2024 -A$32.87 Million-22.49%
2023 -A$42.41 Million-13.52%
2022 -A$49.04 Million34.04%
2021 -A$36.59 Million182.17%
2020 -A$12.97 Million-55.97%
2019 -A$29.45 Million14.17%
2018 -A$25.79 Million95.14%
2017 -A$13.22 Million-22.32%
2016 -A$17.02 Million39.1%
2015 -A$12.23 Million-12.89%
2014 -A$14.04 Million89%
2013 -A$7.43 Million26.65%
2012 -A$5.87 Million-26.02%
2011 -A$7.93 Million-288.45%
2010 A$4.2 M-4.17%
2009 A$4.38 M-287.19%
2008 -A$2.35 Million-47.12%
2007 -A$4.44 Million41.78%
2006 -A$3.13 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
A$5.41 B-20,203.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
A$1.12 B-4,277.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Meridian Bioscience
VIVO.defunct
A$80.27 M-398.19%๐Ÿ‡บ๐Ÿ‡ธ USA